Akshay Vaishnaw, President, R&D at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 14,708 shares at $175.00 ($2.6M) on 2021-06-18, disclosed to the SEC on 2021-06-22.
Seasonal sale ($2.6M) by President, R&D — this insider has traded ALNY in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| SRRK | SELL | 2025-05-30 | $353K | — | Filing → |
| ALNY | SELL | 2023-08-07 | $1.4M | — | Filing → |
| ALNY | SELL | 2023-04-28 | $839K | — | Filing → |